1 – 121 of 121
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Care of Late-Stage Parkinsonism : Resource Utilization of the Disease in Five European Countries
(
- Contribution to journal › Article
-
Mark
Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria
2024) In Movement Disorders(
- Contribution to journal › Article
- 2023
-
Mark
Reply to Letter to the Editor : “Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up”
(
- Contribution to journal › Letter
-
Mark
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction Are Altered in Parkinson's Disease and Related Disorders
(
- Contribution to journal › Article
-
Mark
A Screening Tool to Quickly Identify Movement Disorders in Patients with Inborn Errors of Metabolism
(
- Contribution to journal › Article
-
Mark
Dopamine Agonist Cotreatment Alters Neuroplasticity and Pharmacology of Levodopa-Induced Dyskinesia
(
- Contribution to journal › Article
-
Mark
Investigation of Shared Genetic Risk Factors Between Parkinson's Disease and Cancers
(
- Contribution to journal › Article
-
Mark
Does fatigue in Parkinson’s disease impact one’s physical function in daily live?
2023) The 2023 Inational Congress of Parkinson’s Disease and Movement Disorderst(
In Movement Disorders 38(Suppl 1). p.824-824- Contribution to journal › Published meeting abstract
-
Mark
Levodopa Dose Equivalency in Parkinson's Disease : Updated Systematic Review and Proposals
(
- Contribution to journal › Article
-
Mark
Embracing Monogenic Parkinson's Disease : The MJFF Global Genetic PD Cohort
(
- Contribution to journal › Article
- 2022
-
Mark
Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors
(
- Contribution to journal › Article
-
Mark
The Interaction between HLA-DRB1 and Smoking in Parkinson's Disease Revisited
(
- Contribution to journal › Article
-
Mark
Dairy Intake and Parkinson's Disease : A Mendelian Randomization Study
(
- Contribution to journal › Article
-
Mark
The Neuroinflammatory Acute Phase Response in Parkinsonian-Related Disorders
(
- Contribution to journal › Article
- 2021
-
Mark
Comparison of Locus Coeruleus Pathology with Nigral and Forebrain Pathology in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
A Modified Progressive Supranuclear Palsy Rating Scale
(
- Contribution to journal › Article
-
Mark
Plasma Phospho-Tau Identifies Alzheimer's Co-Pathology in Patients with Lewy Body Disease
(
- Contribution to journal › Article
-
Mark
From iPS Cells to Rodents and Nonhuman Primates : Filling Gaps in Modeling Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Can reduced attention or visuoexecutive functioning predict perceived walking difficulties in people with Parkinson’s disease (PD)?
(
- Contribution to journal › Published meeting abstract
-
Mark
Replication of a Novel Parkinson's Locus in a European Ancestry Population
(
- Contribution to journal › Article
-
Mark
Genotype–Phenotype Relations for the Atypical Parkinsonism Genes : MDSGene Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Parkinson's Disease and Post–COVID-19 Syndrome : The Parkinson's Long-COVID Spectrum
(
- Contribution to journal › Debate/Note/Editorial
- 2020
-
Mark
Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders
(
- Contribution to journal › Article
-
Mark
Dyskinesia matters
(
- Contribution to journal › Article
-
Mark
Reply to : Letter to Editor by Chaudhuri, Jenner, Antonini
(
- Contribution to journal › Letter
-
Mark
Alcohol Consumption and Risk of Parkinson's Disease : Data from a Large Prospective European Cohort
(
- Contribution to journal › Article
-
Mark
Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
(
- Contribution to journal › Article
-
Mark
The Parkinson's Disease Genome-Wide Association Study Locus Browser
2020) In Movement Disorders(
- Contribution to journal › Article
-
Mark
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
(
- Contribution to journal › Article
- 2019
-
Mark
EuroInf 2 : Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
2019) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Nomenclature of Genetically Determined Myoclonus Syndromes : Recommendations of the International Parkinson and Movement Disorder Society Task Force
(
- Contribution to journal › Scientific review
-
Mark
Variable Interpretation of the Dystonia Consensus Classification Items Compromises Its Solidity
(
- Contribution to journal › Article
-
Mark
Seeding of protein aggregation causes cognitive impairment in rat model of cortical synucleinopathy
(
- Contribution to journal › Article
- 2018
-
Mark
Eye movement disorders and neurological symptoms in late-onset inborn errors of metabolism
(
- Contribution to journal › Scientific review
-
Mark
Progressive myoclonus ataxia : Time for a new definition?
(
- Contribution to journal › Article
-
Mark
Treatable inherited rare movement disorders
(
- Contribution to journal › Scientific review
-
Mark
Animal models of l-dopa-induced dyskinesia in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's : A longitudinal study
(
- Contribution to journal › Article
- 2017
-
Mark
A post hoc study on gene panel analysis for the diagnosis of dystonia
(
- Contribution to journal › Article
-
Mark
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
(
- Contribution to journal › Scientific review
-
Mark
Factors associated with perceived walking difficulties in people with Parkinson’s disease
(
- Contribution to journal › Published meeting abstract
-
Mark
PBB3 imaging in Parkinsonian disorders : Evidence for binding to tau and other proteins
(
- Contribution to journal › Article
-
Mark
Clinical diagnosis of progressive supranuclear palsy : The movement disorder society criteria
(
- Contribution to journal › Article
-
Mark
Dystonia-deafness syndrome caused by a β-actin gene mutation and response to deep brain stimulation
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy
(
- Contribution to journal › Article
- 2016
-
Mark
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.
2016) In Movement Disorders(
- Contribution to journal › Article
-
Mark
On the Effect of Eltoprazine in Dyskinetic Hemiparkinsonian Rats.
(
- Contribution to journal › Letter
-
Mark
Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Aberrant nigral diffusion in Parkinson's disease : A longitudinal diffusion tensor imaging study
(
- Contribution to journal › Article
-
Mark
Time on timing : Dissociating premature responding from interval sensitivity in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
(
- Contribution to journal › Article
-
Mark
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
(
- Contribution to journal › Article
-
Mark
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
(
- Contribution to journal › Article
-
Mark
Integrated Safety of Levodopa-Carbidopa Intestinal Gel From Prospective Clinical Trials.
(
- Contribution to journal › Article
-
Mark
Heterozygous PINK1 p.G411S mutation increases risk for Parkinson's disease (PD)
2016) 20th International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 31(Suppl. S2). p.282-282(
- Contribution to journal › Published meeting abstract
-
Mark
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
(
- Contribution to journal › Article
- 2015
-
Mark
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results
(
- Contribution to journal › Article
-
Mark
Zooming in on the small: The plasticity of striatal dendritic spines in l-DOPA-Induced dyskinesia.
(
- Contribution to journal › Article
-
Mark
EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.
(
- Contribution to journal › Article
- 2014
-
Mark
Alpha-Synuclein Repeat Variants and Survival in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Flt3 ligand does not differentiate between Parkinsonian disorders.
(
- Contribution to journal › Article
-
Mark
The spectrum of cognitive impairment in Lewy body diseases
(
- Contribution to journal › Scientific review
-
Mark
Ramsay hunt syndrome : Clinical characterization of progressive myoclonus ataxia caused by GOSR2 mutation
(
- Contribution to journal › Article
-
Mark
Neuroacanthocytosis - Clinical variability (a report on six cases)
2014) Eighteenth International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 29(Suppl 1). p.194-194(
- Contribution to journal › Published meeting abstract
-
Mark
Health-related quality of life in early Parkinson's disease : the impact of nonmotor symptoms
(
- Contribution to journal › Article
-
Mark
Plasma Melatonin Is Reduced in Huntington's Disease
(
- Contribution to journal › Article
- 2013
-
Mark
Developing dopaminergic cell therapy for Parkinson's disease-give up or move forward?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Variability in Neuronal Expression of Dopamine Receptors and Transporters in the Substantia Nigra
(
- Contribution to journal › Article
-
Mark
Population-specific Frequencies for LRRK2 Susceptibility Variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium
(
- Contribution to journal › Article
-
Mark
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
(
- Contribution to journal › Scientific review
-
Mark
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Cell therapy for Parkinson's disease: what next?
(
- Contribution to journal › Article
-
Mark
Future falls and/or near falls in people with Parkinson’s disease: Sensitivity and specificity of two retropulsion tests
2013) International Congress of Parkinson's Disease and Movement Disorders, 2013 In Movement Disorders 28(S1). p.163-163(
- Contribution to journal › Published meeting abstract
-
Mark
Trophic Factor Gene Therapy for Parkinson's Disease
(
- Contribution to journal › Scientific review
-
Mark
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Graft-Induced Dyskinesias in Parkinson's Disease: High Striatal Serotonin/Dopamine Transporter Ratio
(
- Contribution to journal › Article
- 2010
-
Mark
Gene Therapy
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Glial Cell Derived Neurotrophic Factor Does not Provide Neuroprotection Against Alpha-Synuclein-Induced Toxicity in a Rat Model of Parkinson's Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Fatigue Rating Scales Critique and Recommendations by the Movement Disorders Society Task Force on Rating Scales for Parkinson's Disease
(
- Contribution to journal › Scientific review
-
Mark
Current Evidence of PD Nursing: Where Do We Go from Here?
(
- Contribution to journal › Published meeting abstract
-
Mark
Hereditary Parkinson's Disease of Unknown Genetic Cause in Two Families from Southern Sweden
2010) 24th Annual Symposium on Etiology, Pathogenesis and Treatment of Parkinsons Disease and Other Movement Disorders In Movement Disorders 25(6).(
- Contribution to journal › Published meeting abstract
-
Mark
Long-Term Results of a Multicenter Study on Subthalamic and Pallidal Stimulation in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Outcome Measures and What These Mean to Patients
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterization of Lewy Body Pathology in 12-and 16-Year Old Intrastriatal Mesencephalic Grafts Surviving in a Patient with Parkinson's Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
The Role of Norepinephrine Neurons in Motor Symptoms of Parkinson's Disease and Development of L-DOPA-Induced Dyskinesia
(
- Contribution to journal › Published meeting abstract
-
Mark
Immunohistochemical Detection of Fosb/Delta fosb-Like Proteins Maps Areas of Maladaptive Neuroplasticity in the Post-Mortem Parkinsonian Brain
(
- Contribution to journal › Published meeting abstract
-
Mark
Post- Versus Pre-Synaptic Plasticity
(
- Contribution to journal › Published meeting abstract
-
Mark
Characterisation of Behavioural and Neurodegenerative Changes Induced by Intranigral 6-Hydroxydopamine Lesions in a Mouse Model of Parkinson's Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
Study of Intracerebroventricular Administration of SNN0031 (rhPDGF-BB) to Patients with Parkinson's Disease (PD), Using an Implanted Pump System
(
- Contribution to journal › Published meeting abstract
-
Mark
Initial Validation of a Self-Administered Version of the Freezing of Gait Questionnaire (FOGQsa)
(
- Contribution to journal › Published meeting abstract
-
Mark
Role of Serotonin Neurons in the Development of L-DOPA-Induced Dyskinesias
(
- Contribution to journal › Published meeting abstract
-
Mark
Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Gene therapy for Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
LRRK2 variation and Parkinson's disease in African Americans
(
- Contribution to journal › Article
-
Mark
Presentation, Diagnosis, and Management of Multiple System Atrophy in Europe: Final Analysis of the European Multiple System Atrophy Registry
(
- Contribution to journal › Article
- 2009
-
Mark
Long-Term Effects of Pallidal or Subthalamic Deep Brain Stimulation on Quality of Life in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Unverricht-Lundborg disease-A misnomer?
(
- Contribution to journal › Letter
-
Mark
No brain structure abnormalities in boys with Tourette's syndrome: A voxel-based morphometry study
(
- Contribution to journal › Article
- 2008
-
Mark
Red flags for multiple system atrophy
(
- Contribution to journal › Article
-
Mark
Deep brain stimulation in Parkinson's disease following fetal nigral transplantation
(
- Contribution to journal › Article
-
Mark
Multicenter study on deep brain stimulation in Parkinson's disease: An independent assessment of reported adverse events at 4 years
(
- Contribution to journal › Article
- 2007
-
Mark
High dose levodopa therapy is not toxic in multiple system atrophy: Experimental evidence
(
- Contribution to journal › Article
-
Mark
Cocaine- and amphetamine-regulated transcript is increased in Huntington disease.
(
- Contribution to journal › Article
- 2006
-
Mark
Health-related quality of life in multiple system atrophy
(
- Contribution to journal › Article
-
Mark
Balance performance, falls and fear of falling in severe Parkinson’s disease (PD).
(
- Contribution to journal › Published meeting abstract
-
Mark
Falls and fall-related self-efficacy in patients with Parkinson’s disease treated with subthalamic deep brain stimulation.
2006) The Movement Disorder Society’s tenth international congress of Parkinson’s disease and Movement Disorders. In Movement Disorders 21(S15). p.687-687(
- Contribution to journal › Published meeting abstract
- 2005
-
Mark
Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson's disease treated with subthalamic deep brain stimulation.
(
- Contribution to journal › Article
- 2003
-
Mark
Health status measurement in Parkinson's disease: Validity of the PDQ-39 and Nottingham Health Profile.
(
- Contribution to journal › Scientific review
-
Mark
Long-term efficacy of thalamic deep brain stimulation for tremor: Double-blind assessments.
(
- Contribution to journal › Article
- 2002
-
Mark
Deep brain stimulation for Parkinson's disease: Patient selection and evaluation
(
- Contribution to journal › Article
-
Mark
Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
(
- Contribution to journal › Article
- 2000
-
Mark
Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease
(
- Contribution to journal › Article
- 1999
-
Mark
Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale
(
- Contribution to journal › Article
-
Mark
Dyskinesias assessment : From CAPIT to CAPSIT. Core Assessment Program for Intracerebral Transplantations. Core Assessment Program for Surgical Interventional Therapies
(
- Contribution to journal › Article
-
Mark
Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)
(
- Contribution to journal › Article
- 1998
-
Mark
Pregnancy in Parkinson's disease: a review of the literature and a case report
(
- Contribution to journal › Article
- 1992
-
Mark
Core assessment program for intracerebral transplantations (CAPIT)
(
- Contribution to journal › Article